Bio Protocol vs Stader — how do they compare? Bio Protocol trades at Rp517.49 (market cap Rp1,15T, Rp264,79M 24h volume), while Stader trades at Rp2,079 (market cap Rp146,58M, Rp16,28M 24h volume). The key difference: Bio Protocol is far larger — about 7845.5× Stader's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 70,8M / 120M SD (59%) for Stader. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Stader for 11 Days on average.
| BIO | SD | |
|---|---|---|
Market Cap | Rp1,15T | Rp146,58M |
Volume (24h) | Rp264,79M | Rp16,28M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 70,8M / 120M SD (59%) |
Typical Hold Time | 16 Days | 11 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Stader (SD) is currently trading at Rp 2,074 with a market cap of Rp 146.58 million, showing a bearish technical signal driven by moving averages while oscillators remain neutral. The token's circulating supply is 70.8 million out of a max 120 million, with an average hold time of 11 days. Recent ecosystem activity is limited, with no major protocol upgrades or significant on-chain developments reported in the crypto space.
Overall outlook is cautious due to bearish momentum and thin liquidity. Key opportunities include potential recovery if broader crypto market sentiment improves, but major risks involve high volatility, low trading volume, and lack of recent fundamental catalysts. Investors should monitor for any new network updates or exchange listings that could impact price action.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Stader is developing staking middleware for various PoS networks, offering modular smart contracts for third-party solutions. In the short term, it will launch contracts on blockchains like Terra and Ethereum to support yield farming and Gaming. Long-term, Stader will encourage third-party staking applications on its platform.
Read more on SD →